The Patent Finder
US

Process for Production of an Abuse-Proofed Solid Dosage Form

US 8,114,384 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Feb 14, 2024 on the fee record · Medium confidence

Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.

Third maintenance fee unpaid; grace period ended.

Filed Jul 14, 2004 as application 10/890,704 · Granted Feb 14, 2012
Base term, 20 years from filing, plus 377 days of patent term adjustment (USPTO delay)
Today
Lapsed Feb 14, 2024
2004 2026
Clock starts
Jul 14, 2004
No longer in force
Feb 14, 2024
Granted
Feb 14, 2012
Term would have run to
Jul 26, 2025
base term patent term adjustment after the term ends fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
377
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
34
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Jul 26, 2025: its 20-year base term plus 377 days of term adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 14, 2004, when this application, 10/890,704, was filedJul 14, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+377 days, USPTO patent term adjustment recordJul 26, 2025High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidlapsed Feb 14, 2024High confidence
Computed term endThe steps above, in orderFeb 14, 2024Medium confidence

Partial family

US 8,114,383Term ended
no later than Oct 2024
no later than Oct 2024
US 8,114,384this patent
Feb 2024
Feb 2024
Application 10/890,763Abandoned
not computed
not computed
Application PCT/EP2004/008792PCT application
no patent term
no patent term
Application PCT/EP2004/014679PCT application
no patent term
no patent term
Application 11/348,295Abandoned
not computed
not computed
US 8,075,872Term ended
no later than Nov 2023
no later than Nov 2023
Application 11/471,438Abandoned
not computed
not computed
8 of 34 applications in this family shown, earliest filings first. Partial: 4 of the 34 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 17, 2008
Reel 21842, frame 654
Arkenau, Elisabeth, DR.; Bartholomaus, Johannes, DR.Gruenenthal GmbHAssignment of Assignor's Interest
Dec 9, 2010
Reel 25456, frame 172
Endo Pharmaceuticals Inc.JPMorgan Chase Bank, N.A., as Administrative AgentConfirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Jul 8, 2011
Reel 26561, frame 978
Endo Pharmaceuticals Inc.Morgan Stanley Senior Funding, Inc., as Administrative AgentSecurity Interest in Exclusively Licensed Patents
Jul 12, 2011
Reel 26577, frame 357
JPMorgan Chase Bank N.A., as Administrative AgentEndo Pharmaceuticals Inc.Release of Security Interest in Exclusively Licensed Patents Recorded at Reel/Frame 25456/172
Mar 3, 2014
Reel 32380, frame 157
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Solutions Inc.Release of Patent Security Interest in Exclusively Licensed Patents
Mar 20, 2014
Reel 32491, frame 620
Endo Pharmaceuticals, Inc.Deutsche Bank AG New York Branch, as Collateral AgentGrant of Security Interest in Licensed Patents
Mar 24, 2014
Reel 32513, frame 255
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Inc.Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents..
Apr 28, 2017
Reel 42362, frame 1
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.; Endo Pharmaceuticals Solutions, Inc.; Astora Women's Health Holdings, LLCRelease of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals Solutions, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchAstora Women's Health Holdings, LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited